Mohamed Yassin
Hamad Medical Corporation
4
4
0
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jean-Charles Grivel
Sidra Medicine
Shared therapeutic areas:
Worked with same sponsors:
Francesco Donati
Laboratorio Antidoping FMSI, Rome, Italy
Shared therapeutic areas:
Worked with same sponsors:
Mohammed Alsayrafi
ADLQ
Shared therapeutic areas:
Worked with same sponsors:
Sven Voss
ADLQ
Shared therapeutic areas:
Worked with same sponsors:
Christophe Raynaud
Sidra Medicine
Shared therapeutic areas:
Worked with same sponsors:
Costas Georgakopoulos
ADLQ
Shared therapeutic areas:
Worked with same sponsors:
Jorge Cortes, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Brigitte C Widemann, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
John Mascarenhas, MD
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Mary Horowitz, MD
Center for International Blood and Marrow Transplant Research
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Using DNA-Typing and Erythrocyte Microparticle Analysis to Detect Blood Doping
Denosumab Versus Zoledronic Acid in Thalassemia-Induced Osteoporosis
18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms
Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology Group
All 4 trials loaded